Psychological factors associated with substance use initiation during the COVID-19 pandemic
•COVID-19 psychological factors may be risk factors for substance use initiation.•COVID-19-related worry is specifically related to using substances to cope during the pandemic.•COVID-19-related psychological factors may require specific clinical attention. The 2019 outbreak of the novel coronavirus...
Uloženo v:
| Vydáno v: | Psychiatry research Ročník 293; s. 113407 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Ireland
Elsevier B.V
01.11.2020
|
| Témata: | |
| ISSN: | 0165-1781, 1872-7123, 1872-7123 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | •COVID-19 psychological factors may be risk factors for substance use initiation.•COVID-19-related worry is specifically related to using substances to cope during the pandemic.•COVID-19-related psychological factors may require specific clinical attention.
The 2019 outbreak of the novel coronavirus (COVID-19) has had a devastating impact. Given the on-going nature of the outbreak, the deleterious toll on mental health, including substance use, is unknown. Negative reinforcement models of substance use posit that elevations in stress from the COVID-19 pandemic will elicit a corresponding motivation to downregulate COVID-19-related stress reactivity via substance use for a subset of the population. The current study sought to evaluate: (1) if COVID-19-related worry and fear were associated with substance use coping motives; and (2) how levels of COVID-19-related worry and fear differ between pre-COVID-19 substance users, COVID-19 substance initiators, and abstainers. Participants were 160 adults recruited nationally between April-May 2020 for an online study. Results indicated that COVID-19-related worry was associated with substance use coping motives. Additionally, compared to abstainers, pre-COVID-19 substance users and COVID-19 substance initiators demonstrated the highest levels of worry and fear. Examination of differences suggested that the COVID-19 substance initiators had the highest COVID-19-related worry and fear for all substances except for opioids, with effect size estimates ranging from small to medium. The results of this study suggest that COVID-19-specific psychological factors appear to be involved in substance use behavior. |
|---|---|
| AbstractList | •COVID-19 psychological factors may be risk factors for substance use initiation.•COVID-19-related worry is specifically related to using substances to cope during the pandemic.•COVID-19-related psychological factors may require specific clinical attention.
The 2019 outbreak of the novel coronavirus (COVID-19) has had a devastating impact. Given the on-going nature of the outbreak, the deleterious toll on mental health, including substance use, is unknown. Negative reinforcement models of substance use posit that elevations in stress from the COVID-19 pandemic will elicit a corresponding motivation to downregulate COVID-19-related stress reactivity via substance use for a subset of the population. The current study sought to evaluate: (1) if COVID-19-related worry and fear were associated with substance use coping motives; and (2) how levels of COVID-19-related worry and fear differ between pre-COVID-19 substance users, COVID-19 substance initiators, and abstainers. Participants were 160 adults recruited nationally between April-May 2020 for an online study. Results indicated that COVID-19-related worry was associated with substance use coping motives. Additionally, compared to abstainers, pre-COVID-19 substance users and COVID-19 substance initiators demonstrated the highest levels of worry and fear. Examination of differences suggested that the COVID-19 substance initiators had the highest COVID-19-related worry and fear for all substances except for opioids, with effect size estimates ranging from small to medium. The results of this study suggest that COVID-19-specific psychological factors appear to be involved in substance use behavior. The 2019 outbreak of the novel coronavirus (COVID-19) has had a devastating impact. Given the on-going nature of the outbreak, the deleterious toll on mental health, including substance use, is unknown. Negative reinforcement models of substance use posit that elevations in stress from the COVID-19 pandemic will elicit a corresponding motivation to downregulate COVID-19-related stress reactivity via substance use for a subset of the population. The current study sought to evaluate: (1) if COVID-19-related worry and fear were associated with substance use coping motives; and (2) how levels of COVID-19-related worry and fear differ between pre-COVID-19 substance users, COVID-19 substance initiators, and abstainers. Participants were 160 adults recruited nationally between April-May 2020 for an online study. Results indicated that COVID-19-related worry was associated with substance use coping motives. Additionally, compared to abstainers, pre-COVID-19 substance users and COVID-19 substance initiators demonstrated the highest levels of worry and fear. Examination of differences suggested that the COVID-19 substance initiators had the highest COVID-19-related worry and fear for all substances except for opioids, with effect size estimates ranging from small to medium. The results of this study suggest that COVID-19-specific psychological factors appear to be involved in substance use behavior.The 2019 outbreak of the novel coronavirus (COVID-19) has had a devastating impact. Given the on-going nature of the outbreak, the deleterious toll on mental health, including substance use, is unknown. Negative reinforcement models of substance use posit that elevations in stress from the COVID-19 pandemic will elicit a corresponding motivation to downregulate COVID-19-related stress reactivity via substance use for a subset of the population. The current study sought to evaluate: (1) if COVID-19-related worry and fear were associated with substance use coping motives; and (2) how levels of COVID-19-related worry and fear differ between pre-COVID-19 substance users, COVID-19 substance initiators, and abstainers. Participants were 160 adults recruited nationally between April-May 2020 for an online study. Results indicated that COVID-19-related worry was associated with substance use coping motives. Additionally, compared to abstainers, pre-COVID-19 substance users and COVID-19 substance initiators demonstrated the highest levels of worry and fear. Examination of differences suggested that the COVID-19 substance initiators had the highest COVID-19-related worry and fear for all substances except for opioids, with effect size estimates ranging from small to medium. The results of this study suggest that COVID-19-specific psychological factors appear to be involved in substance use behavior. • COVID-19 psychological factors may be risk factors for substance use initiation. • COVID-19-related worry is specifically related to using substances to cope during the pandemic. • COVID-19-related psychological factors may require specific clinical attention. The 2019 outbreak of the novel coronavirus (COVID-19) has had a devastating impact. Given the on-going nature of the outbreak, the deleterious toll on mental health, including substance use, is unknown. Negative reinforcement models of substance use posit that elevations in stress from the COVID-19 pandemic will elicit a corresponding motivation to downregulate COVID-19-related stress reactivity via substance use for a subset of the population. The current study sought to evaluate: (1) if COVID-19-related worry and fear were associated with substance use coping motives; and (2) how levels of COVID-19-related worry and fear differ between pre-COVID-19 substance users, COVID-19 substance initiators, and abstainers. Participants were 160 adults recruited nationally between April-May 2020 for an online study. Results indicated that COVID-19-related worry was associated with substance use coping motives. Additionally, compared to abstainers, pre-COVID-19 substance users and COVID-19 substance initiators demonstrated the highest levels of worry and fear. Examination of differences suggested that the COVID-19 substance initiators had the highest COVID-19-related worry and fear for all substances except for opioids, with effect size estimates ranging from small to medium. The results of this study suggest that COVID-19-specific psychological factors appear to be involved in substance use behavior. The 2019 outbreak of the novel coronavirus (COVID-19) has had a devastating impact. Given the on-going nature of the outbreak, the deleterious toll on mental health, including substance use, is unknown. Negative reinforcement models of substance use posit that elevations in stress from the COVID-19 pandemic will elicit a corresponding motivation to downregulate COVID-19-related stress reactivity via substance use for a subset of the population. The current study sought to evaluate: (1) if COVID-19-related worry and fear were associated with substance use coping motives; and (2) how levels of COVID-19-related worry and fear differ between pre-COVID-19 substance users, COVID-19 substance initiators, and abstainers. Participants were 160 adults recruited nationally between April-May 2020 for an online study. Results indicated that COVID-19-related worry was associated with substance use coping motives. Additionally, compared to abstainers, pre-COVID-19 substance users and COVID-19 substance initiators demonstrated the highest levels of worry and fear. Examination of differences suggested that the COVID-19 substance initiators had the highest COVID-19-related worry and fear for all substances except for opioids, with effect size estimates ranging from small to medium. The results of this study suggest that COVID-19-specific psychological factors appear to be involved in substance use behavior. |
| ArticleNumber | 113407 |
| Author | Garey, Lorra Zvolensky, Michael J. Shepherd, Justin M. Rogers, Andrew H. |
| Author_xml | – sequence: 1 givenname: Andrew H. surname: Rogers fullname: Rogers, Andrew H. organization: Department of Psychology, University of Houston, USA – sequence: 2 givenname: Justin M. surname: Shepherd fullname: Shepherd, Justin M. organization: Department of Psychology, University of Houston, USA – sequence: 3 givenname: Lorra surname: Garey fullname: Garey, Lorra organization: Department of Psychology, University of Houston, USA – sequence: 4 givenname: Michael J. surname: Zvolensky fullname: Zvolensky, Michael J. email: mjzvolen@central.uh.edu organization: Department of Psychology, University of Houston, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32827993$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkk9vEzEQxS1URNPCV6h85LKp_-zaawlVoEChUqVyAC4cLGd2kjhs1sH2FuXb45C2gl6KZMnSzHu_seb5hBwNYUBCzjibcsbV-Xq6TTtYRUxTwUQpclkz_YxMeKtFpbmQR2RShE3FdcuPyUlKa8aY4Ma8IMdStEIbIyfk--c9JvRh6cH1dOEgh5ioSymAdxk7-svnFU3jPGU3ANIxIfWDz6Xpw0C7MfphSfMK6ezm29X7ihu6dUOHGw8vyfOF6xO-urtPydfLD19mn6rrm49Xs3fXFTRC5cp1Na81CNOCUgrA6Jo1DShn6rkqp2k6I1UjNS5QSAmOS-g0q6FU6xaYPCUXB-52nG-wAxxydL3dRr9xcWeD8_bfzuBXdhlura5lLRUvgNd3gBh-jpiy3fgE2PduwDAmK4pKmsaYpkjP_p71MOR-o0WgDgKIIaWIiwcJZ3YfnV3b--jsPjp7iK4Y3zwygs9_llze7Pun7W8PdiybvvUYbQKPJbHOR4Rsu-CfRlw8QkBfoi7_4gfu_gfwG4I9z6c |
| CitedBy_id | crossref_primary_10_1097_YCO_0000000000000708 crossref_primary_10_1080_16506073_2020_1861084 crossref_primary_10_1177_11782218221123977 crossref_primary_10_1097_YCO_0000000000000707 crossref_primary_10_3389_fpsyt_2021_633551 crossref_primary_10_1016_j_drugalcdep_2021_108770 crossref_primary_10_1371_journal_pone_0285310 crossref_primary_10_3390_computation12060118 crossref_primary_10_3390_socsci12080464 crossref_primary_10_1016_j_drugalcdep_2022_109349 crossref_primary_10_3390_diagnostics12051125 crossref_primary_10_1038_s41598_025_14568_x crossref_primary_10_1186_s13033_023_00585_8 crossref_primary_10_1371_journal_pone_0270582 crossref_primary_10_3389_fpsyg_2021_667848 crossref_primary_10_1016_j_drugalcdep_2023_110971 crossref_primary_10_1097_ADT_0000000000000260 crossref_primary_10_1016_j_abrep_2021_100392 crossref_primary_10_1016_j_brat_2022_104141 crossref_primary_10_1016_j_neubiorev_2022_104720 crossref_primary_10_3389_fpubh_2024_1426922 crossref_primary_10_1080_03069885_2024_2311209 crossref_primary_10_1016_j_cegh_2021_100885 crossref_primary_10_1080_15332640_2022_2091702 crossref_primary_10_1016_j_comppsych_2025_152598 crossref_primary_10_2196_30833 crossref_primary_10_1080_10826084_2024_2330902 crossref_primary_10_1186_s12888_024_06305_x crossref_primary_10_3389_fpsyt_2020_587455 crossref_primary_10_1186_s13011_021_00396_5 crossref_primary_10_3390_ijerph19031659 crossref_primary_10_1111_dar_13531 crossref_primary_10_1371_journal_pone_0306280 crossref_primary_10_1080_16506073_2020_1866657 crossref_primary_10_1177_02654075211006199 crossref_primary_10_3390_bs12110453 crossref_primary_10_1177_14550725221135574 crossref_primary_10_1007_s40429_025_00651_w crossref_primary_10_1371_journal_pone_0289413 crossref_primary_10_1177_08901171231188187 crossref_primary_10_1016_j_whi_2022_09_002 crossref_primary_10_1093_ntr_ntac205 crossref_primary_10_1111_bjc_12351 crossref_primary_10_12688_f1000research_52535_2 crossref_primary_10_1177_02698811251346729 crossref_primary_10_12688_f1000research_52535_1 crossref_primary_10_3389_fpsyt_2021_603318 crossref_primary_10_1016_j_jcrimjus_2024_102172 crossref_primary_10_3389_fpsyg_2023_1228515 crossref_primary_10_1016_j_abrep_2022_100455 crossref_primary_10_1016_j_neuroscience_2023_11_014 crossref_primary_10_3389_fpsyg_2020_589365 crossref_primary_10_1007_s10608_022_10292_2 crossref_primary_10_1111_eip_13385 crossref_primary_10_2196_59076 crossref_primary_10_1177_23294965211011591 crossref_primary_10_1007_s40615_025_02553_z crossref_primary_10_1111_add_15387 crossref_primary_10_1016_j_addbeh_2021_107052 crossref_primary_10_1080_16066359_2022_2134991 crossref_primary_10_1002_jcop_22864 crossref_primary_10_3389_fpsyg_2021_703948 crossref_primary_10_1016_j_addbeh_2021_107213 crossref_primary_10_1007_s11414_024_09905_3 crossref_primary_10_1080_16506073_2021_1877340 crossref_primary_10_1007_s10900_023_01253_1 crossref_primary_10_1097_CXA_0000000000000148 crossref_primary_10_1016_j_jad_2024_12_108 crossref_primary_10_1080_09638237_2021_1922636 crossref_primary_10_1186_s12889_023_17068_7 crossref_primary_10_3389_fpsyt_2021_753383 crossref_primary_10_1186_s12889_022_14798_y crossref_primary_10_1016_j_whi_2023_02_001 crossref_primary_10_1080_16506073_2021_1874504 crossref_primary_10_1007_s11469_021_00620_0 crossref_primary_10_1016_j_healthplace_2022_102885 crossref_primary_10_1093_alcalc_agab067 crossref_primary_10_1080_00952990_2023_2165939 crossref_primary_10_1016_j_addbeh_2023_107724 crossref_primary_10_3389_fpubh_2022_875801 crossref_primary_10_1016_j_gaceta_2023_102346 crossref_primary_10_1080_15332640_2022_2128960 crossref_primary_10_1186_s12889_021_11241_6 crossref_primary_10_1111_pere_12480 crossref_primary_10_1371_journal_pclm_0000300 crossref_primary_10_1136_ihj_2022_000125 crossref_primary_10_1016_j_drugpo_2023_104238 crossref_primary_10_1038_s41398_021_01614_1 crossref_primary_10_1016_j_drugpo_2021_103384 crossref_primary_10_1177_10731911241240618 crossref_primary_10_1055_a_2244_4254 crossref_primary_10_3390_healthcare10081366 crossref_primary_10_1007_s11469_021_00678_w crossref_primary_10_1080_16506073_2021_1897667 crossref_primary_10_1016_j_drugalcdep_2021_109150 crossref_primary_10_3390_ijerph182212155 crossref_primary_10_1080_10810730_2023_2279668 crossref_primary_10_1080_07481187_2024_2386068 crossref_primary_10_1016_j_jmig_2020_12_024 crossref_primary_10_1097_ADM_0000000000000977 crossref_primary_10_1080_16506073_2022_2079557 crossref_primary_10_1371_journal_pone_0265900 crossref_primary_10_3390_ijerph191811577 crossref_primary_10_2147_RMHP_S359507 crossref_primary_10_1016_j_ijhm_2021_103009 crossref_primary_10_1007_s12529_021_10036_8 crossref_primary_10_1186_s41256_022_00280_0 crossref_primary_10_1097_01_NAJ_0000925496_18847_c6 crossref_primary_10_1016_j_dadr_2022_100027 crossref_primary_10_1002_etc_5217 crossref_primary_10_1177_21582440221100455 crossref_primary_10_1016_j_dadr_2023_100186 crossref_primary_10_1007_s11469_021_00751_4 crossref_primary_10_1007_s11469_022_00991_y crossref_primary_10_1089_jwh_2023_0013 crossref_primary_10_1080_08897077_2021_1941513 crossref_primary_10_3389_fpsyt_2022_1037451 crossref_primary_10_1007_s10608_021_10252_2 crossref_primary_10_1080_17538068_2021_2013054 crossref_primary_10_1080_00952990_2022_2134021 crossref_primary_10_1016_j_addbeh_2021_107092 crossref_primary_10_1038_s41598_024_63008_9 crossref_primary_10_1177_21582440231219589 crossref_primary_10_3390_ijerph18094960 crossref_primary_10_1016_j_drugalcdep_2021_109015 crossref_primary_10_1080_15332640_2025_2494228 crossref_primary_10_1016_j_jpsychores_2023_111424 crossref_primary_10_1080_15332640_2024_2403561 crossref_primary_10_1192_j_eurpsy_2025_2450 |
| Cites_doi | 10.1016/j.janxdis.2009.07.006 10.1016/S2215-0366(20)30090-0 10.1007/BF00931236 10.1186/s12888-016-1191-0 10.1016/j.drugalcdep.2013.12.008 10.1002/jts.2490090316 10.1056/NEJMoa2002032 10.1001/jamahealthforum.2020.0628 10.1016/j.psychres.2020.113047 10.1037/0033-2909.112.1.155 10.1177/0091450915570309 10.1016/S2589-7500(20)30026-1 10.7326/M20-1212 10.1016/j.dsx.2020.06.008 10.1037/a0024519 10.1016/j.psychres.2020.113096 10.1016/j.paid.2004.05.005 10.1016/j.jsat.2008.08.005 10.2106/JBJS.O.00012 10.1111/j.2044-8341.1993.tb01740.x 10.1016/j.edurev.2010.12.001 10.1001/archgenpsychiatry.2010.131 10.1111/j.1467-7717.2009.01136.x 10.3758/s13423-015-0892-6 10.1016/j.neubiorev.2013.08.006 10.1146/annurev-publhealth-032013-182435 10.1037/1082-989X.9.2.147 10.1037/0033-295X.111.1.33 10.4300/JGME-D-12-00156.1 10.1016/0005-7967(90)90135-6 10.1038/s41586-020-2012-7 10.1111/j.1360-0443.2006.01481.x 10.1002/da.22032 10.1007/s40429-020-00321-z 10.1016/j.tips.2016.12.002 10.1186/1471-2458-8-92 10.1037/1040-3590.6.2.117 10.1016/j.jpsychores.2020.110159 10.1001/jama.2020.6548 10.1176/appi.ajp.159.5.857 10.1016/S2215-0366(20)30077-8 10.1016/j.drugalcdep.2016.03.003 |
| ContentType | Journal Article |
| Copyright | 2020 Elsevier B.V. Copyright © 2020 Elsevier B.V. All rights reserved. 2020 Elsevier B.V. All rights reserved. 2020 Elsevier B.V. |
| Copyright_xml | – notice: 2020 Elsevier B.V. – notice: Copyright © 2020 Elsevier B.V. All rights reserved. – notice: 2020 Elsevier B.V. All rights reserved. 2020 Elsevier B.V. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.psychres.2020.113407 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1872-7123 |
| EndPage | 113407 |
| ExternalDocumentID | PMC7434361 32827993 10_1016_j_psychres_2020_113407 S0165178120322563 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29P 4.4 457 4G. 53G 5VS 7-5 71M 8P~ 9JM 9JO AABNK AADFP AAEDT AAEDW AAGJA AAGKA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABIVO ABJNI ABMAC ABMZM ABOYX ABWVN ABXDB ACDAQ ACGFS ACHQT ACIEU ACIUM ACLOT ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEG HMK HMO HMQ HMW HVGLF HZ~ IHE J1W KOM M29 M2V M39 M3V M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OKEIE OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SPCBC SPS SSB SSH SSN SSY SSZ T5K UV1 WUQ Z5R ZGI ~G- ~HD AACTN AADPK AAIAV ABLVK ABYKQ AFCTW AFKWA AFYLN AJBFU AJOXV AMFUW LCYCR RIG ZA5 9DU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c526t-ad4147c298c666cc974055c6a94b64b655d936537efe233ca13cd704c93648c03 |
| ISICitedReferencesCount | 146 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000591588300066&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0165-1781 1872-7123 |
| IngestDate | Tue Sep 30 16:25:48 EDT 2025 Mon Sep 29 04:02:07 EDT 2025 Thu Apr 03 07:08:27 EDT 2025 Sat Nov 29 07:21:48 EST 2025 Tue Nov 18 19:37:09 EST 2025 Fri Feb 23 02:40:08 EST 2024 Tue Oct 14 19:39:06 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | COVID-19 Substance use Coping motives Mental health |
| Language | English |
| License | Copyright © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c526t-ad4147c298c666cc974055c6a94b64b655d936537efe233ca13cd704c93648c03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7434361 |
| PMID | 32827993 |
| PQID | 2436395995 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7434361 proquest_miscellaneous_2436395995 pubmed_primary_32827993 crossref_primary_10_1016_j_psychres_2020_113407 crossref_citationtrail_10_1016_j_psychres_2020_113407 elsevier_sciencedirect_doi_10_1016_j_psychres_2020_113407 elsevier_clinicalkey_doi_10_1016_j_psychres_2020_113407 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-11-01 |
| PublicationDateYYYYMMDD | 2020-11-01 |
| PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Ireland |
| PublicationPlace_xml | – name: Ireland |
| PublicationTitle | Psychiatry research |
| PublicationTitleAlternate | Psychiatry Res |
| PublicationYear | 2020 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Cohen (bib0011) 1992; 112 Keefe, Kraemer, Epstein, Frank, Haynes, Laughren, Mcnulty, Reed, Sanchez, Leon (bib0025) 2013; 10 Cooper (bib0012) 1994; 6 National Institute of Drug Abuse, 2020. Most commonly used addictive drugs. [WWW Document]. URL Sun, Chen, Viboud (bib0044) 2020; 2 David, Mellman, Mendoza, Kulick-Bell, Ironson, Schneiderman (bib0013) 1996; 9 Pisanti, Bifulco (bib0038) 2017; 38 Sullivan, Feinn (bib0043) 2012; 4 Bravo, Rubio-Stipec, Canino, Woodbury, Ribera (bib0006) 1990; 18 Chang, Chen, Mao (bib0009) 2007; 91 Joseph, Yule, Williams, Hodgkinson (bib0024) 1993; 66 Werner, McCutcheon, Agrawal, Sartor, Nelson, Heath, Bucholz (bib0050) 2016; 162 Maxwell (bib0029) 2004; 9 Vadillo, Konstantinidis, Shanks (bib0045) 2016; 23 Wang, Pan, Wan, Tan, Xu, Ho, Ho (bib0049) 2020; 17 Pfefferbaum, North (bib0037) 2020; 0 Hyman, Sinha (bib0023) 2009; 36 Meyer, Miller, Metzger, Borkovec (bib0031) 1990; 28 Guan, Ni, Hu, Liang, Ou, He, Liu, Shan, Lei, Hui, Du, Li, Zeng, Yuen, Chen, Tang, Wang, Chen, Xiang, Li, Wang, Liang, Peng, Wei, Liu, Hu, Peng, Wang, Liu, Chen, Li, Zheng, Qiu, Luo, Ye, Zhu, Zhong (bib0020) 2020; 382 Elliott, Golub, Bennett, Guarino (bib0015) 2015; 42 Liu, Yang, Zhang, Xiang, Liu, Hu, Zhang (bib0027) 2020; 7 Ornell, Moura, Scherer, Pechansky, Kessler, von Diemen (bib0035) 2020; 289 Goldmann, Galea (bib0019) 2014; 35 Behar, DiMarco, Hekler, Mohlman, Staples (bib0003) 2009; 23 on 2020, August 3. Parslow, Jorm (bib0036) 2006; 101 Shoal, Castaneda, Giancola (bib0041) 2005; 38 North, Tivis, McMillen, Pfefferbaum, Spitznagel, Cox, Nixon, Bunch, Smith (bib0034) 2002; 159 North, Ringwalt, Downs, Derzon, Galvin (bib0033) 2011; 68 McHugh, Votaw, Sugarman, Greenfield (bib0030) 2017 Bonn-Miller, Babson, Vandrey (bib0004) 2014; 136 Hussong, Jones, Stein, Baucom, Boeding (bib0022) 2011; 25 Baker, Piper, McCarthy, Majeskie, Fiore (bib0002) 2004; 111 Zhou, Yang, Wang, Hu, Zhang, Zhang, Si, Zhu, Li, Huang, Chen, Chen, Luo, Guo, Jiang, Liu, Chen, Shen, Wang, Zheng, Zhao, Chen, Deng, Liu, Yan, Zhan, Wang, Xiao, Shi (bib0053) 2020; 579 Volkow (bib0048) 2020 Borkovec, Alcaine, Behar (bib0005) 2004 Yancy (bib0051) 2020 Poudel, Gautam (bib0039) 2017; 17 Cepeda, Valdez, Kaplan, Hill (bib0008) 2010; 34 Richardson (bib0040) 2011; 6 Garland, Froeliger, Zeidan, Partin, Howard (bib0017) 2013; 37 Ghosh, Roub, Bisaga (bib0018) 2020; 135 Garey, Olofsson, Garza, Rogers, Kauffman, Zvolensky (bib0016) 2020 Vecchio, Ramella, Drago, Carraro, Littlewood, Somaini (bib0046) 2020; 289 Dubey, Ghosh, Chatterjee, Biswas, Chatterjee, Dubey (bib0014) 2020; 14 Levy, Guttman (bib0026) 1976; 14 Slat, Thomas, Lagisetty (bib0042) 2020; 1 Buckner, Heimberg, Ecker, Vinci (bib0007) 2013; 30 Citrome (bib0010) 2014; 11 Hedges, L.V., 2016. Distribution theory for glass's estimator of effect size and related estimators: J. Educ. Stat. 10.3102/10769986006002107. Yao, Chen, Xu (bib0052) 2020; 7 Vetter, Rossegger, Rossler, Bisson, Endrass (bib0047) 2008; 8 Abdullah, Davis, Fabricant, Baldwin, Namdari (bib0001) 2015; 97 North (10.1016/j.psychres.2020.113407_bib0034) 2002; 159 Cooper (10.1016/j.psychres.2020.113407_bib0012) 1994; 6 Cohen (10.1016/j.psychres.2020.113407_bib0011) 1992; 112 Maxwell (10.1016/j.psychres.2020.113407_bib0029) 2004; 9 Buckner (10.1016/j.psychres.2020.113407_bib0007) 2013; 30 Poudel (10.1016/j.psychres.2020.113407_bib0039) 2017; 17 Werner (10.1016/j.psychres.2020.113407_bib0050) 2016; 162 Levy (10.1016/j.psychres.2020.113407_bib0026) 1976; 14 Abdullah (10.1016/j.psychres.2020.113407_bib0001) 2015; 97 Guan (10.1016/j.psychres.2020.113407_bib0020) 2020; 382 Pisanti (10.1016/j.psychres.2020.113407_bib0038) 2017; 38 Parslow (10.1016/j.psychres.2020.113407_bib0036) 2006; 101 Dubey (10.1016/j.psychres.2020.113407_bib0014) 2020; 14 Hussong (10.1016/j.psychres.2020.113407_bib0022) 2011; 25 Slat (10.1016/j.psychres.2020.113407_bib0042) 2020; 1 Behar (10.1016/j.psychres.2020.113407_bib0003) 2009; 23 Cepeda (10.1016/j.psychres.2020.113407_bib0008) 2010; 34 Sullivan (10.1016/j.psychres.2020.113407_bib0043) 2012; 4 Vadillo (10.1016/j.psychres.2020.113407_bib0045) 2016; 23 Ghosh (10.1016/j.psychres.2020.113407_bib0018) 2020; 135 Richardson (10.1016/j.psychres.2020.113407_bib0040) 2011; 6 10.1016/j.psychres.2020.113407_bib0032 Zhou (10.1016/j.psychres.2020.113407_bib0053) 2020; 579 Keefe (10.1016/j.psychres.2020.113407_bib0025) 2013; 10 Borkovec (10.1016/j.psychres.2020.113407_bib0005) 2004 Pfefferbaum (10.1016/j.psychres.2020.113407_bib0037) 2020; 0 Vetter (10.1016/j.psychres.2020.113407_bib0047) 2008; 8 Yao (10.1016/j.psychres.2020.113407_bib0052) 2020; 7 David (10.1016/j.psychres.2020.113407_bib0013) 1996; 9 Elliott (10.1016/j.psychres.2020.113407_bib0015) 2015; 42 McHugh (10.1016/j.psychres.2020.113407_bib0030) 2017 Bravo (10.1016/j.psychres.2020.113407_bib0006) 1990; 18 Baker (10.1016/j.psychres.2020.113407_bib0002) 2004; 111 10.1016/j.psychres.2020.113407_bib0021 Garey (10.1016/j.psychres.2020.113407_bib0016) 2020 Wang (10.1016/j.psychres.2020.113407_bib0049) 2020; 17 Sun (10.1016/j.psychres.2020.113407_bib0044) 2020; 2 Bonn-Miller (10.1016/j.psychres.2020.113407_bib0004) 2014; 136 Joseph (10.1016/j.psychres.2020.113407_bib0024) 1993; 66 North (10.1016/j.psychres.2020.113407_bib0033) 2011; 68 Meyer (10.1016/j.psychres.2020.113407_bib0031) 1990; 28 Vecchio (10.1016/j.psychres.2020.113407_bib0046) 2020; 289 Liu (10.1016/j.psychres.2020.113407_bib0027) 2020; 7 Shoal (10.1016/j.psychres.2020.113407_bib0041) 2005; 38 Goldmann (10.1016/j.psychres.2020.113407_bib0019) 2014; 35 Ornell (10.1016/j.psychres.2020.113407_bib0035) 2020; 289 Yancy (10.1016/j.psychres.2020.113407_bib0051) 2020 Garland (10.1016/j.psychres.2020.113407_bib0017) 2013; 37 Hyman (10.1016/j.psychres.2020.113407_bib0023) 2009; 36 Citrome (10.1016/j.psychres.2020.113407_bib0010) 2014; 11 Chang (10.1016/j.psychres.2020.113407_bib0009) 2007; 91 Volkow (10.1016/j.psychres.2020.113407_bib0048) 2020 |
| References_xml | – volume: 42 start-page: 60 year: 2015 end-page: 76 ident: bib0015 article-title: PTSD and Cannabis-related coping among recent veterans in New York City publication-title: Contemp. Drug Probl. – volume: 135 year: 2020 ident: bib0018 article-title: Drug treatment of SARS-Cov2: potential effects in patients with substance use disorders (SUD) publication-title: J. Psychosom. Res. – reference: on 2020, August 3. – volume: 289 year: 2020 ident: bib0046 article-title: COVID19 pandemic and people with opioid use disorder: innovation to reduce risk publication-title: Psychiatry Res. – volume: 17 year: 2017 ident: bib0039 article-title: Age of onset of substance use and psychosocial problems among individuals with substance use disorders publication-title: BMC Psychiatry – volume: 30 start-page: 276 year: 2013 end-page: 284 ident: bib0007 article-title: A biopsychosocial model of social anxiety and substance use publication-title: Depression Anxiety – volume: 14 start-page: 211 year: 1976 end-page: 228 ident: bib0026 article-title: Worry, fear, and concern differentiated publication-title: Isr. Ann. Psychiatry Relat. Discipl. – volume: 68 start-page: 173 year: 2011 end-page: 180 ident: bib0033 article-title: Postdisaster course of alcohol use disorders in systematically studied survivors of 10 disasters publication-title: Arch. Gen. Psychiatry – volume: 23 start-page: 87 year: 2016 end-page: 102 ident: bib0045 article-title: Underpowered samples, false negatives, and unconscious learning publication-title: Psychon. Bull. Rev. – volume: 97 start-page: 2068 year: 2015 end-page: 2073 ident: bib0001 article-title: Is there truly “no significant difference”?: Underpowered randomized controlled trials in the orthopaedic literature publication-title: JBJS – volume: 111 start-page: 33 year: 2004 end-page: 51 ident: bib0002 article-title: Addiction motivation reformulated: an affective processing model of negative reinforcement publication-title: Psychol. Rev. – volume: 6 start-page: 117 year: 1994 end-page: 128 ident: bib0012 article-title: Motivations for alcohol use among adolescents: development and validation of a four-factor model publication-title: Psychol. Assess. – reference: National Institute of Drug Abuse, 2020. Most commonly used addictive drugs. [WWW Document]. URL – volume: 6 start-page: 135 year: 2011 end-page: 147 ident: bib0040 article-title: Eta squared and partial eta squared as measures of effect size in educational research publication-title: Educ. Res. Rev. – volume: 289 year: 2020 ident: bib0035 article-title: The COVID-19 pandemic and its impact on substance use: implications for prevention and treatment publication-title: Psychiatry Res. – volume: 23 start-page: 1011 year: 2009 end-page: 1023 ident: bib0003 article-title: Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications publication-title: J. Anxiety Disord. – year: 2017 ident: bib0030 article-title: Sex and gender differences in substance use disorders publication-title: Clin Psychol Rev. – volume: 34 start-page: 426 year: 2010 end-page: 446 ident: bib0008 article-title: Patterns of substance use among Hurricane Katrina evacuees in Houston, Texas publication-title: Disasters – volume: 11 start-page: 26 year: 2014 end-page: 30 ident: bib0010 article-title: Quantifying clinical relevance publication-title: Innov. Clin. Neurosci. – volume: 17 year: 2020 ident: bib0049 article-title: Immediate psychological responses and associated factors during the initial stage of the 2019 Coronavirus Disease (COVID-19) epidemic among the general population in China publication-title: Int. J. Environ. Res. Public Health – volume: 10 year: 2013 ident: bib0025 article-title: Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials publication-title: Innov. Clin. Neurosci. – volume: 91 start-page: 199 year: 2007 end-page: 211 ident: bib0009 article-title: Opioid tolerance and hyperalgesia publication-title: Med. Clin. – volume: 35 start-page: 169 year: 2014 end-page: 183 ident: bib0019 article-title: Mental health consequences of disasters publication-title: Annu. Rev. Public Health – volume: 66 start-page: 185 year: 1993 end-page: 191 ident: bib0024 article-title: Increased substance use in survivors of the Herald of Free Enterprise disaster publication-title: Br. J. Med. Psychol. – volume: 162 start-page: 162 year: 2016 end-page: 169 ident: bib0050 article-title: The association of specific traumatic experiences with cannabis initiation and transition to problem use: differences between African-American and European-American women publication-title: Drug Alcohol Depend. – volume: 36 start-page: 400 year: 2009 end-page: 413 ident: bib0023 article-title: Stress-related factors in cannabis use and misuse: implications for prevention and treatment publication-title: J. Subst. Abuse Treat. – year: 2020 ident: bib0051 article-title: COVID-19 and African Americans publication-title: JAMA. – volume: 1 year: 2020 ident: bib0042 article-title: Coronavirus disease 2019 and opioid use—a pandemic within an epidemic publication-title: JAMA Health Forum – volume: 37 start-page: 2597 year: 2013 end-page: 2607 ident: bib0017 article-title: The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways publication-title: Neurosci. Biobehav. Rev. – volume: 579 start-page: 270 year: 2020 end-page: 273 ident: bib0053 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature – volume: 7 start-page: e17 year: 2020 end-page: e18 ident: bib0027 article-title: Online mental health services in China during the COVID-19 outbreak publication-title: Lancet Psychiatry – volume: 9 start-page: 607 year: 1996 end-page: 612 ident: bib0013 article-title: Psychiatric morbidity following Hurricane Andrew publication-title: J. Trauma Stress – volume: 7 start-page: e21 year: 2020 ident: bib0052 article-title: Patients with mental health disorders in the COVID-19 epidemic publication-title: Lancet Psychiatry – volume: 8 start-page: 92 year: 2008 ident: bib0047 article-title: Exposure to the tsunami disaster, PTSD symptoms and increased substance use – an internet based survey of male and female residents of Switzerland publication-title: BMC Public Health – volume: 159 start-page: 857 year: 2002 end-page: 859 ident: bib0034 article-title: Psychiatric disorders in rescue workers after the Oklahoma City bombing publication-title: Am. J. Psychiatry – volume: 4 start-page: 279 year: 2012 end-page: 282 ident: bib0043 article-title: Using effect size—or why the P value is not enough publication-title: J. Grad. Med. Educ. – year: 2020 ident: bib0048 article-title: Collision of the COVID-19 and addiction epidemics publication-title: Ann. Intern. Med. – volume: 2 start-page: e201 year: 2020 end-page: e208 ident: bib0044 article-title: Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study publication-title: Lancet Digit. Health – volume: 38 start-page: 475 year: 2005 end-page: 485 ident: bib0041 article-title: Worry moderates the relation between negative affectivity and affect-related substance use in adolescent males: a prospective study of maladaptive emotional self-regulation publication-title: Personal. Individ. Differ. – volume: 101 start-page: 1044 year: 2006 end-page: 1050 ident: bib0036 article-title: Tobacco use after experiencing a major natural disaster: analysis of a longitudinal study of 2063 young adults publication-title: Addiction – volume: 25 start-page: 390 year: 2011 end-page: 404 ident: bib0022 article-title: An internalizing pathway to alcohol and substance use disorders publication-title: Psychol. Addict. Behav. – reference: Hedges, L.V., 2016. Distribution theory for glass's estimator of effect size and related estimators: J. Educ. Stat. 10.3102/10769986006002107. – volume: 28 start-page: 487 year: 1990 end-page: 495 ident: bib0031 article-title: Development and validation of the penn state worry questionnaire publication-title: Behav. Res. Ther. – volume: 0 year: 2020 ident: bib0037 article-title: Mental Health and the Covid-19 Pandemic publication-title: N. Engl. J. Med. – year: 2020 ident: bib0016 article-title: Directional effects of anxiety and depressive disorders with substance use: a review of recent prospective research publication-title: Curr. Addict. Rep. – volume: 38 start-page: 195 year: 2017 end-page: 198 ident: bib0038 article-title: Modern history of medical cannabis: from widespread use to prohibitionism and back publication-title: Trends Pharmacol. Sci. – start-page: 77 year: 2004 end-page: 108 ident: bib0005 article-title: Avoidance theory of worry and generalized anxiety disorder publication-title: Generalized Anxiety Disorder: Advances in Research and Practice – volume: 112 start-page: 155 year: 1992 end-page: 159 ident: bib0011 article-title: A power primer publication-title: Psychol. Bull. – volume: 382 start-page: 1708 year: 2020 end-page: 1720 ident: bib0020 article-title: China Medical Treatment Expert Group for Covid-19, 2020. Clinical characteristics of coronavirus disease 2019 in China publication-title: N. Engl. J. Med. – volume: 9 start-page: 147 year: 2004 end-page: 163 ident: bib0029 article-title: The persistence of underpowered studies in psychological research: causes, consequences, and remedies publication-title: Psychol. Methods – volume: 14 start-page: 817 year: 2020 end-page: 823 ident: bib0014 article-title: COVID-19 and addiction publication-title: Diabetes Metab. Syndr. – volume: 136 start-page: 162 year: 2014 end-page: 165 ident: bib0004 article-title: Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD publication-title: Drug Alcohol Depend. – volume: 18 start-page: 661 year: 1990 end-page: 680 ident: bib0006 article-title: The psychological sequelae of disaster stress prospectively and retrospectively evaluated publication-title: Am. J. Community Psychol. – volume: 23 start-page: 1011 year: 2009 ident: 10.1016/j.psychres.2020.113407_bib0003 article-title: Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications publication-title: J. Anxiety Disord. doi: 10.1016/j.janxdis.2009.07.006 – volume: 7 start-page: e21 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0052 article-title: Patients with mental health disorders in the COVID-19 epidemic publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30090-0 – start-page: 77 year: 2004 ident: 10.1016/j.psychres.2020.113407_bib0005 article-title: Avoidance theory of worry and generalized anxiety disorder – volume: 11 start-page: 26 year: 2014 ident: 10.1016/j.psychres.2020.113407_bib0010 article-title: Quantifying clinical relevance publication-title: Innov. Clin. Neurosci. – ident: 10.1016/j.psychres.2020.113407_bib0021 – volume: 10 year: 2013 ident: 10.1016/j.psychres.2020.113407_bib0025 article-title: Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials publication-title: Innov. Clin. Neurosci. – volume: 18 start-page: 661 year: 1990 ident: 10.1016/j.psychres.2020.113407_bib0006 article-title: The psychological sequelae of disaster stress prospectively and retrospectively evaluated publication-title: Am. J. Community Psychol. doi: 10.1007/BF00931236 – volume: 17 year: 2017 ident: 10.1016/j.psychres.2020.113407_bib0039 article-title: Age of onset of substance use and psychosocial problems among individuals with substance use disorders publication-title: BMC Psychiatry doi: 10.1186/s12888-016-1191-0 – volume: 136 start-page: 162 year: 2014 ident: 10.1016/j.psychres.2020.113407_bib0004 article-title: Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2013.12.008 – volume: 9 start-page: 607 year: 1996 ident: 10.1016/j.psychres.2020.113407_bib0013 article-title: Psychiatric morbidity following Hurricane Andrew publication-title: J. Trauma Stress doi: 10.1002/jts.2490090316 – volume: 382 start-page: 1708 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0020 article-title: China Medical Treatment Expert Group for Covid-19, 2020. Clinical characteristics of coronavirus disease 2019 in China publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2002032 – volume: 1 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0042 article-title: Coronavirus disease 2019 and opioid use—a pandemic within an epidemic publication-title: JAMA Health Forum doi: 10.1001/jamahealthforum.2020.0628 – volume: 289 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0046 article-title: COVID19 pandemic and people with opioid use disorder: innovation to reduce risk publication-title: Psychiatry Res. doi: 10.1016/j.psychres.2020.113047 – volume: 91 start-page: 199 year: 2007 ident: 10.1016/j.psychres.2020.113407_bib0009 article-title: Opioid tolerance and hyperalgesia publication-title: Med. Clin. – volume: 112 start-page: 155 year: 1992 ident: 10.1016/j.psychres.2020.113407_bib0011 article-title: A power primer publication-title: Psychol. Bull. doi: 10.1037/0033-2909.112.1.155 – year: 2017 ident: 10.1016/j.psychres.2020.113407_bib0030 article-title: Sex and gender differences in substance use disorders publication-title: Clin Psychol Rev. – volume: 42 start-page: 60 year: 2015 ident: 10.1016/j.psychres.2020.113407_bib0015 article-title: PTSD and Cannabis-related coping among recent veterans in New York City publication-title: Contemp. Drug Probl. doi: 10.1177/0091450915570309 – volume: 2 start-page: e201 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0044 article-title: Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study publication-title: Lancet Digit. Health doi: 10.1016/S2589-7500(20)30026-1 – year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0048 article-title: Collision of the COVID-19 and addiction epidemics publication-title: Ann. Intern. Med. doi: 10.7326/M20-1212 – volume: 14 start-page: 817 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0014 article-title: COVID-19 and addiction publication-title: Diabetes Metab. Syndr. doi: 10.1016/j.dsx.2020.06.008 – volume: 25 start-page: 390 year: 2011 ident: 10.1016/j.psychres.2020.113407_bib0022 article-title: An internalizing pathway to alcohol and substance use disorders publication-title: Psychol. Addict. Behav. doi: 10.1037/a0024519 – volume: 289 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0035 article-title: The COVID-19 pandemic and its impact on substance use: implications for prevention and treatment publication-title: Psychiatry Res. doi: 10.1016/j.psychres.2020.113096 – volume: 38 start-page: 475 year: 2005 ident: 10.1016/j.psychres.2020.113407_bib0041 article-title: Worry moderates the relation between negative affectivity and affect-related substance use in adolescent males: a prospective study of maladaptive emotional self-regulation publication-title: Personal. Individ. Differ. doi: 10.1016/j.paid.2004.05.005 – volume: 36 start-page: 400 year: 2009 ident: 10.1016/j.psychres.2020.113407_bib0023 article-title: Stress-related factors in cannabis use and misuse: implications for prevention and treatment publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2008.08.005 – volume: 97 start-page: 2068 year: 2015 ident: 10.1016/j.psychres.2020.113407_bib0001 article-title: Is there truly “no significant difference”?: Underpowered randomized controlled trials in the orthopaedic literature publication-title: JBJS doi: 10.2106/JBJS.O.00012 – volume: 66 start-page: 185 year: 1993 ident: 10.1016/j.psychres.2020.113407_bib0024 article-title: Increased substance use in survivors of the Herald of Free Enterprise disaster publication-title: Br. J. Med. Psychol. doi: 10.1111/j.2044-8341.1993.tb01740.x – volume: 6 start-page: 135 year: 2011 ident: 10.1016/j.psychres.2020.113407_bib0040 article-title: Eta squared and partial eta squared as measures of effect size in educational research publication-title: Educ. Res. Rev. doi: 10.1016/j.edurev.2010.12.001 – volume: 68 start-page: 173 year: 2011 ident: 10.1016/j.psychres.2020.113407_bib0033 article-title: Postdisaster course of alcohol use disorders in systematically studied survivors of 10 disasters publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2010.131 – volume: 34 start-page: 426 year: 2010 ident: 10.1016/j.psychres.2020.113407_bib0008 article-title: Patterns of substance use among Hurricane Katrina evacuees in Houston, Texas publication-title: Disasters doi: 10.1111/j.1467-7717.2009.01136.x – volume: 0 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0037 article-title: Mental Health and the Covid-19 Pandemic publication-title: N. Engl. J. Med. – volume: 23 start-page: 87 year: 2016 ident: 10.1016/j.psychres.2020.113407_bib0045 article-title: Underpowered samples, false negatives, and unconscious learning publication-title: Psychon. Bull. Rev. doi: 10.3758/s13423-015-0892-6 – volume: 37 start-page: 2597 year: 2013 ident: 10.1016/j.psychres.2020.113407_bib0017 article-title: The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2013.08.006 – volume: 35 start-page: 169 year: 2014 ident: 10.1016/j.psychres.2020.113407_bib0019 article-title: Mental health consequences of disasters publication-title: Annu. Rev. Public Health doi: 10.1146/annurev-publhealth-032013-182435 – volume: 9 start-page: 147 year: 2004 ident: 10.1016/j.psychres.2020.113407_bib0029 article-title: The persistence of underpowered studies in psychological research: causes, consequences, and remedies publication-title: Psychol. Methods doi: 10.1037/1082-989X.9.2.147 – volume: 111 start-page: 33 year: 2004 ident: 10.1016/j.psychres.2020.113407_bib0002 article-title: Addiction motivation reformulated: an affective processing model of negative reinforcement publication-title: Psychol. Rev. doi: 10.1037/0033-295X.111.1.33 – volume: 14 start-page: 211 year: 1976 ident: 10.1016/j.psychres.2020.113407_bib0026 article-title: Worry, fear, and concern differentiated publication-title: Isr. Ann. Psychiatry Relat. Discipl. – volume: 4 start-page: 279 year: 2012 ident: 10.1016/j.psychres.2020.113407_bib0043 article-title: Using effect size—or why the P value is not enough publication-title: J. Grad. Med. Educ. doi: 10.4300/JGME-D-12-00156.1 – volume: 28 start-page: 487 year: 1990 ident: 10.1016/j.psychres.2020.113407_bib0031 article-title: Development and validation of the penn state worry questionnaire publication-title: Behav. Res. Ther. doi: 10.1016/0005-7967(90)90135-6 – volume: 579 start-page: 270 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0053 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature doi: 10.1038/s41586-020-2012-7 – volume: 101 start-page: 1044 year: 2006 ident: 10.1016/j.psychres.2020.113407_bib0036 article-title: Tobacco use after experiencing a major natural disaster: analysis of a longitudinal study of 2063 young adults publication-title: Addiction doi: 10.1111/j.1360-0443.2006.01481.x – volume: 17 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0049 article-title: Immediate psychological responses and associated factors during the initial stage of the 2019 Coronavirus Disease (COVID-19) epidemic among the general population in China publication-title: Int. J. Environ. Res. Public Health – volume: 30 start-page: 276 year: 2013 ident: 10.1016/j.psychres.2020.113407_bib0007 article-title: A biopsychosocial model of social anxiety and substance use publication-title: Depression Anxiety doi: 10.1002/da.22032 – year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0016 article-title: Directional effects of anxiety and depressive disorders with substance use: a review of recent prospective research publication-title: Curr. Addict. Rep. doi: 10.1007/s40429-020-00321-z – volume: 38 start-page: 195 year: 2017 ident: 10.1016/j.psychres.2020.113407_bib0038 article-title: Modern history of medical cannabis: from widespread use to prohibitionism and back publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2016.12.002 – volume: 8 start-page: 92 year: 2008 ident: 10.1016/j.psychres.2020.113407_bib0047 article-title: Exposure to the tsunami disaster, PTSD symptoms and increased substance use – an internet based survey of male and female residents of Switzerland publication-title: BMC Public Health doi: 10.1186/1471-2458-8-92 – volume: 6 start-page: 117 year: 1994 ident: 10.1016/j.psychres.2020.113407_bib0012 article-title: Motivations for alcohol use among adolescents: development and validation of a four-factor model publication-title: Psychol. Assess. doi: 10.1037/1040-3590.6.2.117 – volume: 135 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0018 article-title: Drug treatment of SARS-Cov2: potential effects in patients with substance use disorders (SUD) publication-title: J. Psychosom. Res. doi: 10.1016/j.jpsychores.2020.110159 – year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0051 article-title: COVID-19 and African Americans publication-title: JAMA. doi: 10.1001/jama.2020.6548 – volume: 159 start-page: 857 year: 2002 ident: 10.1016/j.psychres.2020.113407_bib0034 article-title: Psychiatric disorders in rescue workers after the Oklahoma City bombing publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.159.5.857 – volume: 7 start-page: e17 year: 2020 ident: 10.1016/j.psychres.2020.113407_bib0027 article-title: Online mental health services in China during the COVID-19 outbreak publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30077-8 – ident: 10.1016/j.psychres.2020.113407_bib0032 – volume: 162 start-page: 162 year: 2016 ident: 10.1016/j.psychres.2020.113407_bib0050 article-title: The association of specific traumatic experiences with cannabis initiation and transition to problem use: differences between African-American and European-American women publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2016.03.003 |
| SSID | ssj0002199 |
| Score | 2.6378708 |
| Snippet | •COVID-19 psychological factors may be risk factors for substance use initiation.•COVID-19-related worry is specifically related to using substances to cope... The 2019 outbreak of the novel coronavirus (COVID-19) has had a devastating impact. Given the on-going nature of the outbreak, the deleterious toll on mental... • COVID-19 psychological factors may be risk factors for substance use initiation. • COVID-19-related worry is specifically related to using substances to cope... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 113407 |
| SubjectTerms | Adaptation, Psychological Adult Anxiety - epidemiology Anxiety - psychology Coping motives COVID-19 Fear - psychology Female Humans Male Mental Health Motivation Quarantine - psychology SARS-CoV-2 Substance use Substance-Related Disorders - epidemiology Substance-Related Disorders - psychology |
| Title | Psychological factors associated with substance use initiation during the COVID-19 pandemic |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0165178120322563 https://dx.doi.org/10.1016/j.psychres.2020.113407 https://www.ncbi.nlm.nih.gov/pubmed/32827993 https://www.proquest.com/docview/2436395995 https://pubmed.ncbi.nlm.nih.gov/PMC7434361 |
| Volume | 293 |
| WOSCitedRecordID | wos000591588300066&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1872-7123 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002199 issn: 0165-1781 databaseCode: AIEXJ dateStart: 20200201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEF6lLUK8IM4SjmqReLMc7D283seqFNpKLRUqKIIHa7N2aarKiXKp_4E_zaz3SNwCbR-QIitaezZez-fZmckcCL0rs4TBLlyCbVKqmPGkjGXO8jjhxGSiJ1WiT5tmE-LoKO_35XGn88vnwiwuRF3nl5dy_F9ZDWPAbJM6ewd2h0lhAL4D0-EIbIfjrRjfFmm-n45ybPDR5lMQGLMmXWA-NXVDhjPLI5-3aPTRnc_f9j_EqYzGxtNss5eDJnscwqQjVzAoOJa_jH66zms2XDLa6wVHzpkJKrPh9E0jsTo6DCc_qYlzoI8mk7BdfF-Y0AHn43VR_tFBb9VdAbZpGtwVzoOZ8TgVtk-LF8FE0hUhmqaU2Va41-S7dTWc95pQcFhdz_xEb0nQLqh9ZaML4Yc-su288PMUZp7CzrOGNojgEkTkxvb-bv8gbOzEtiMNK1hJOP_zHf1N17luy1wNyV3RcU4eoYfOOMHbFlSPUaeqn6D7hy784in60cIWdtjCS2xhgy0csIUBW3iJLWyxhQFb2GMLe2w9Q18_7p7s7MWuO0esOclmsSpZyoQmMtdgAmsNhmnCuc6UZIMMPpyXkmaciuq0IpRqlVJdioRpGGUgBehztF6P6uoFwkyJckDywQC0T8YVVZJUipRsUJruCYx0EffPsdCudL3poHJR_JuTXfQ-0I1t8ZYbKYRnU-FTk2EzLQB_N1LKQOmUV6uU3or2rUdEAdLd_GWn6mo0h4sYBRPCFAXsok2LkLASSnIiwLyAe25hJ1xgKse3z9TDs6aCvDD55Fn68s7P5xV6sHypX6P12WRevUH39GI2nE620Jro51vutfkNR3Tp6w |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psychological+factors+associated+with+substance+use+initiation+during+the+COVID-19+pandemic&rft.jtitle=Psychiatry+research&rft.au=Rogers%2C+Andrew+H.&rft.au=Shepherd%2C+Justin+M.&rft.au=Garey%2C+Lorra&rft.au=Zvolensky%2C+Michael+J.&rft.date=2020-11-01&rft.issn=0165-1781&rft.volume=293&rft.spage=113407&rft_id=info:doi/10.1016%2Fj.psychres.2020.113407&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_psychres_2020_113407 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0165-1781&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0165-1781&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0165-1781&client=summon |